Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: th...
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
About this item
Full title
Author / Creator
Shah, Manish A. , Shitara, Kohei , Ajani, Jaffer A. , Bang, Yung-Jue , Enzinger, Peter , Ilson, David , Lordick, Florian , Van Cutsem, Eric , Gallego Plazas, Javier , Huang, Jing , Shen, Lin , Oh, Sang Cheul , Sunpaweravong, Patrapim , Soo Hoo, Hwoei Fen , Turk, Haci Mehmet , Oh, Mok , Park, Jung Wook , Moran, Diarmuid , Bhattacharya, Pranob , Arozullah, Ahsan and Xu, Rui-Hua
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
There is an urgent need for first-line treatment options for patients with human epidermal growth factor receptor 2 (HER2)-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma. Claudin-18 isoform 2 (CLDN18.2) is expressed in normal gastric cells and maintained in malignant G/GEJ adenocar...
Alternative Titles
Full title
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
Authors, Artists and Contributors
Author / Creator
Shitara, Kohei
Ajani, Jaffer A.
Bang, Yung-Jue
Enzinger, Peter
Ilson, David
Lordick, Florian
Van Cutsem, Eric
Gallego Plazas, Javier
Huang, Jing
Shen, Lin
Oh, Sang Cheul
Sunpaweravong, Patrapim
Soo Hoo, Hwoei Fen
Turk, Haci Mehmet
Oh, Mok
Park, Jung Wook
Moran, Diarmuid
Bhattacharya, Pranob
Arozullah, Ahsan
Xu, Rui-Hua
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10427418
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10427418
Other Identifiers
ISSN
1078-8956,1546-170X
E-ISSN
1546-170X
DOI
10.1038/s41591-023-02465-7
